drugset / Trial / NCT04283474
Phase 1 XG005-03 Topical Study
RandomizedSequentialSingle-blindBasic science
Summary
Phase 1, randomized, single-blinded, placebo-control, ascending single and multiple dose of the PK, safety, and tolerability of XG005-03 topical formulation in Healthy Volunteers.
Timeline
- Start
- 2020-02-28
- Primary completion
- 2021-01-28
- Completion
- 2021-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XG005-03 | Unknown | 1 % | Topical |
| Subject | XG005-03 | Unknown | 5 % | Topical |
| Subject | XG005-03 | Unknown | 10 % | Topical |
Indications
No indication recorded.